CLDND1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.058400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.241000E-01
Normal-vs-Stage2
9.010200E-01
Normal-vs-Stage3
3.294200E-01
Normal-vs-Stage4
7.175200E-01
Stage1-vs-Stage2
8.903400E-01
Stage1-vs-Stage3
1.840210E-01
Stage1-vs-Stage4
7.925200E-01
Stage2-vs-Stage3
3.124000E-01
Stage2-vs-Stage4
6.783000E-01
Stage3-vs-Stage4
3.430400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.197800E-01
Normal-vs-AfricanAmerican
8.856400E-01
Normal-vs-Asian
9.818400E-01
Caucasian-vs-AfricanAmerican
7.578200E-01
Caucasian-vs-Asian
8.948200E-01
AfricanAmerican-vs-Asian
8.767400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.164400E-01
Normal-vs-Female
8.722000E-01
Male-vs-Female
9.297800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.227600E-01
Normal-vs-Age(41-60Yrs)
4.583800E-01
Normal-vs-Age(61-80Yrs)
8.989800E-01
Normal-vs-Age(81-100Yrs)
3.663800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.823800E-03
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.116200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.834600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.280400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.199410E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.145200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.337000E-01
Normal-vs-Daily Drinker
8.960400E-01
Normal-vs-Weekly Drinker
4.919000E-01
Normal-vs-Occasional Drinker
5.304400E-01
Normal-vs-Social Drinker
9.128200E-01
Non Drinker-vs-Daily Drinker
2.577600E-01
Non Drinker-vs-Weekly Drinker
7.759200E-01
Non Drinker-vs-Occasional Drinker
4.335800E-02
Non Drinker-vs-Social Drinker
2.939400E-01
Daily Drinker-vs-Weekly Drinker
2.750800E-01
Daily Drinker-vs-Occasional Drinker
3.426200E-01
Daily Drinker-vs-Social Drinker
9.382600E-01
Weekly Drinker-vs-Occasional Drinker
4.723800E-02
Weekly Drinker-vs-Social Drinker
2.618800E-01
Occasional Drinker-vs-Social Drinker
3.155400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.195960E-01
Normal-vs-Grade 2
9.305000E-03
Normal-vs-Grade 3
3.797800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.386100E-02
Grade 1-vs-Grade 3
1.905980E-01
Grade 1-vs-Grade 4
1.195960E-01
Grade 2-vs-Grade 3
6.659800E-01
Grade 2-vs-Grade 4
9.305000E-03
Grade 3-vs-Grade 4
3.797800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.664200E-01
Normal-vs-NonDiabetic
9.557000E-01
Diabetic-vs-NonDiabetic
7.593600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.163400E-01
Normal-vs-NoPancreatitis
9.754200E-01
Pancreatitis-vs-NoPancreatitis
7.906000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.106600E-01
Normal-vs-N1
9.115000E-01
N0-vs-N1
9.914200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.492370E-01
Normal-vs-TP53-NonMutant
6.677400E-01
TP53-Mutant-vs-TP53-NonMutant
5.330400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
